Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual disease

Fig. 3

NETest levels in GNENs comparing image-positive and –negative disease. The NETest was significantly higher in image-positive (gastroscopy and anatomical and/or functional imaging) disease (28 ± 7) compared to controls (7 ± 4, p < 0.0001). This was significantly increased compared to levels in image-negative (gastroscopy and anatomical and/or functional imaging) and histology-negative subjects (16 ± 11, p = 0.002). NETest levels in image-positive and histology-positive disease (28 ± 7) were not different to histology-positive but image-negative disease (28 ± 9, p = ns). In the histology-positive disease, the NETest scores reflected low disease activity (stable disease). Mean ± SD. Dotted line: NETest upper limit of normal (20%)

Back to article page